Search
Close this search box.

The Difference Between Basal Cell Carcinoma and Squamous Cell Carcinoma

Basal cell carcinoma and squamous cell carcinoma are the two most common types of skin cancers. According to the American Cancer Society, over 5 million cases of basal cell and squamous cell cancers are diagnosed every year. Though, basal cell carcinoma occurs more often, taking credit for about 80% of these cases. Other than the […]

How to Stop the Recurrence of Keloid Scars with SRT Treatment

Have your patients tried surgical methods of keloid removal, only to find that the keloid scar returns stronger than ever after the operation? Keloid scars are often very difficult to treat, because surgery can send the wrong signals to the skin to restart the wound healing process. This mix-up can lead to a keloid scar […]

Sensus Healthcare to Present at the Ladenburg Thalmann 2017 Healthcare Conference

BOCA RATON, Fla., Sept. 20, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that management will present at the Ladenburg Thalmann Healthcare Conference on Tuesday, September 26, 2017 at 4:00 p.m. Eastern time. The […]

SRT: Innovating a Proven Treatment for Skin Cancer Treatment

Innovating upon a tried-and-true technology, an updated device is available for dermatologists to use to fight skin cancer. By Jeffrey Fromowitz, MD, FAAD As a dermatologist in practice in Boca Raton, FL, I am at the front lines of the ever-growing skin cancer epidemic. As such, I am always searching for new tools that allow me […]

Sensus Healthcare to Present at Upcoming Investor Conferences

Management unable to present at Liolios Gateway conference due to Hurricane Irma BOCA RATON, Fla., Sept. 05, 2017 — Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, will present […]